IDH2 and acute myeloid leukemia: Recently another addition to this sub-group was made due to the discovery that mutations in the Wilms tumor gene WT1, which are found in approximately 10% of AML, are also mutually exclusive with TET and IDH mutations and display global cytosine hydroxymethylation profiles reminiscent of IDH and TET mutated AML.